Literature DB >> 10433571

Cure of implantable venous port-associated bloodstream infections in pediatric hematology-oncology patients without catheter removal.

L G Rubin1, S Shih, A Shende, G Karayalcin, P Lanzkowsky.   

Abstract

The efficacy of antibiotic treatment of port-associated bloodstream infection without device removal has not been systematically studied. We analyzed the outcome of 43 consecutive port-associated bloodstream infections in pediatric hematology-oncology patients. Etiologies included Staphylococcus epidermidis (30) and Staphylococcus aureus (6). Antibiotics were given through the port for a median of 11 days. Four ports were removed within 72 hours. In 36 (92%) of the remaining 39 episodes, there was a response to antibiotic therapy (defervescence and negative blood culture). In 78% of episodes in which there was a response (excluding two in which the catheters were removed because of mechanical problems), the infections were cured without port removal. Two of the four relapses were cured with a second course of antibiotics. The cure rate was 92% for S. epidermidis infections and 67% for S. aureus infections. Thus, the majority of port-associated bloodstream infections in pediatric hematology-oncology patients can be cured without device removal.

Entities:  

Mesh:

Year:  1999        PMID: 10433571     DOI: 10.1086/520135

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  9 in total

1.  Validity of earlier positivity of central venous blood cultures in comparison with peripheral blood cultures for diagnosing catheter-related bacteremia in cancer patients.

Authors:  V B Malgrange; M C Escande; S Theobald
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

2.  Stability of antibiotics used for antibiotic-lock treatment of infections of implantable venous devices (ports).

Authors:  T U Anthony; L G Rubin
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

Review 3.  Infections associated with medical devices: pathogenesis, management and prophylaxis.

Authors:  Christof von Eiff; Bernd Jansen; Wolfgang Kohnen; Karsten Becker
Journal:  Drugs       Date:  2005       Impact factor: 9.546

4.  Efficacy of intravascular catheter lock solutions containing preservatives in the prevention of microbial colonization.

Authors:  L E Shenep; M A Shenep; W Cheatham; J M Hoffman; A Hale; B F Williams; R Perkins; C B Hewitt; R T Hayden; J L Shenep
Journal:  J Hosp Infect       Date:  2011-09-25       Impact factor: 3.926

5.  Vancomycin and ceftazidime bioactivities persist for at least 2 weeks in the lumen in ports: simplifying treatment of port-associated bloodstream infections by using the antibiotic lock technique.

Authors:  Y Haimi-Cohen; N Husain; J Meenan; G Karayalcin; M Lehrer; L G Rubin
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

6.  Central venous catheter salvage in children with Staphylococcus aureus central line-associated bloodstream infection.

Authors:  Kristine S Corkum; Rachel E Jones; Caroline H Reuter; Larry K Kociolek; Elaine Morgan; Timothy B Lautz
Journal:  Pediatr Surg Int       Date:  2017-09-25       Impact factor: 1.827

Review 7.  Staphylococcal skin infections in children: rational drug therapy recommendations.

Authors:  Shamez Ladhani; Mehdi Garbash
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

Review 8.  Catheter-related infections in children treated with hemodialysis.

Authors:  Fabio Paglialonga; Susanna Esposito; Alberto Edefonti; Nicola Principi
Journal:  Pediatr Nephrol       Date:  2004-12       Impact factor: 3.714

9.  Outcome of antibiotic lock technique for persistent central venous catheter-associated coagulase-negative Staphylococcus bacteremia in children.

Authors:  O Megged; I Shalit; I Yaniv; S Fisher; G Livni; I Levy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-11-13       Impact factor: 3.267

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.